Improvement of barrier integrity in hiv patients

A - Human Necessities – 23 – L

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A23L 1/30 (2006.01) A23L 1/308 (2006.01) A61K 31/201 (2006.01) A61K 31/202 (2006.01) A61P 31/18 (2006.01)

Patent

CA 2570208

The invention concerns a method for stimulating intestinal barrier integrity in a patient infected with HIV by administering to said patient composition comprising: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and arachidonic acid (ARA), and at least two distinct oligosaccharides.

L'invention concerne une méthode de stimulation de l'intégrité de la barrière intestinale chez un patient infecté par le VIH, consistant à administrer audit patient une composition contenant de l'acide éicosapentaénoïque (EPA), de l'acide docosahexaénoïque (DHA) et de l'acide arachidonique (ARA), et au moins deux oligosaccharides distincts.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Improvement of barrier integrity in hiv patients does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Improvement of barrier integrity in hiv patients, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improvement of barrier integrity in hiv patients will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1389821

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.